Verona Pharma Management
Management criteria checks 3/4
Verona Pharma's CEO is Dave Zaccardelli, appointed in Feb 2020, has a tenure of 4.25 years. total yearly compensation is $6.60M, comprised of 12.4% salary and 87.6% bonuses, including company stock and options. directly owns 1.96% of the company’s shares, worth $24.46M. The average tenure of the management team and the board of directors is 2.2 years and 5.1 years respectively.
Key information
Dave Zaccardelli
Chief executive officer
US$6.6m
Total compensation
| CEO salary percentage | 12.4% |
| CEO tenure | 4.3yrs |
| CEO ownership | 2.0% |
| Management average tenure | 2.2yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
Is Verona Pharma (NASDAQ:VRNA) Using Too Much Debt?
Apr 26
Verona Pharma: A Few Points From The Bull And Bear Case
Feb 15Is Verona Pharma (NASDAQ:VRNA) A Risky Investment?
Jan 26Verona Pharma: Upcoming PDUFA, Expired Patent, Strong Data
Jan 19Health Check: How Prudently Does Verona Pharma (NASDAQ:VRNA) Use Debt?
Oct 12Does Verona Pharma (NASDAQ:VRNA) Have A Healthy Balance Sheet?
Jun 27Verona Pharma (NASDAQ:VRNA) Has Debt But No Earnings; Should You Worry?
Mar 10Is Verona Pharma (NASDAQ:VRNA) Using Debt In A Risky Way?
Dec 02Verona: Expected End Of 2022 Catalyst Could Provide Value Inflection Point
Sep 13Verona stock rises as partner Nuance gets China regulator nod to start lung disease drug trials
Aug 19Verona Pharma GAAP EPS of -$0.04 beats by $0.23
Aug 09Verona Pharma: First Inhaled Product Candidate Combining Anti-Inflammatory And Bronchodilator Effects, A Potential Blockbuster
Feb 04Verona Pharma's ensifentrine successful in mid-stage lung disease study; shares up 8%
Feb 02Enrollment completed in Verona Pharma's study of pMDI ensifentrine in COVID-19
Jan 14Verona Pharma EPS beats by $0.15
Oct 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$7m | US$820k | -US$54m |
| Sep 30 2023 | n/a | n/a | -US$51m |
| Jun 30 2023 | n/a | n/a | -US$52m |
| Mar 31 2023 | n/a | n/a | -US$61m |
| Dec 31 2022 | US$5m | US$525k | -US$69m |
| Sep 30 2022 | n/a | n/a | -US$82m |
| Jun 30 2022 | n/a | n/a | -US$55m |
| Mar 31 2022 | n/a | n/a | -US$59m |
| Dec 31 2021 | US$1m | US$273k | -US$56m |
| Sep 30 2021 | n/a | n/a | -US$57m |
| Jun 30 2021 | n/a | n/a | -US$87m |
| Mar 31 2021 | n/a | n/a | -US$74m |
| Dec 31 2020 | US$18m | US$229k | -US$65m |
Compensation vs Market: Dave's total compensation ($USD6.60M) is about average for companies of similar size in the US market ($USD5.72M).
Compensation vs Earnings: Dave's compensation has increased whilst the company is unprofitable.
CEO
Dave Zaccardelli (59 yo)
4.3yrs
Tenure
US$6,597,473
Compensation
Dr. David S. Zaccardelli, also known as Dave, Pharm D., has been President, Chief Executive Officer and Executive Director of Verona Pharma plc since February 1, 2020. Dr. Zaccardelli has been Director of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$6.60m | 1.96% $ 24.5m | |
| Chief Financial Officer | 4.2yrs | US$6.18m | 1.81% $ 22.7m | |
| Chief Medical Officer | 5.3yrs | US$1.98m | 0.25% $ 3.1m | |
| General Counsel | less than a year | no data | no data | |
| Director of Communications | no data | no data | no data | |
| VP of Sales | 1.8yrs | no data | no data | |
| Senior Vice President of Human Resources | 1.7yrs | no data | no data | |
| Chief Development Officer | no data | no data | no data | |
| Chief Commercial Officer | no data | no data | no data | |
| Senior Vice President of Regulatory Affairs | 2.6yrs | no data | no data | |
| Senior Vice President of Medical Affairs | 1.3yrs | no data | no data | |
| Company Secretary | no data | no data | no data |
2.2yrs
Average Tenure
59yo
Average Age
Experienced Management: VRNA's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$6.60m | 1.96% $ 24.5m | |
| Independent Non-Executive Director | 7.8yrs | US$224.83k | 0.011% $ 141.1k | |
| Independent Non-Executive Director | 5.1yrs | US$219.74k | 0.022% $ 279.6k | |
| Independent Non-Executive Director | 8.7yrs | US$232.47k | 0.010% $ 128.6k | |
| Independent Non-Executive Chairman | 9.4yrs | US$330.50k | 0.13% $ 1.6m | |
| Independent Non-Executive Director | 8.7yrs | US$219.74k | 0.052% $ 646.7k | |
| Independent Non-Executive Director | 7.7yrs | US$238.83k | 0.011% $ 143.8k | |
| Non-Executive Director | less than a year | US$267.91k | no data | |
| Independent Non-Executive Director | 3.2yrs | US$223.56k | 0.011% $ 135.8k | |
| Independent Non-Executive Director | 2.2yrs | US$226.10k | 0% $ 0 | |
| Independent Non-Executive Director | less than a year | no data | no data |
5.1yrs
Average Tenure
61yo
Average Age
Experienced Board: VRNA's board of directors are considered experienced (5.1 years average tenure).